et_marketsabout 10 hours ago
BEARISH(80%)
sell
Speciality Medicines IPO opens today. Check price band, GMP, subscription and other details
Read original source-1.3
Market Impact Score
-100 Bearish+100 Bullish
AI Analysis
The pharma sector is driven by R&D and market expansion. IPOs in niche segments can offer growth, but investor caution is warranted for new listings without strong initial premiums.
Trading Insight
Observe subscription levels, particularly from Qualified Institutional Buyers (QIBs), to assess genuine demand.
Quick check: SUNPHARMA bearish bias (-1.8% 1d), CIPLA bearish bias (oversold).
Key Evidence
- •Speciality Medicines' IPO opens Friday, aiming to raise Rs 29 crore.
- •Flat 0% grey market premium (GMP) indicates cautious investor sentiment.
- •Plans to use IPO proceeds for R&D, international registrations, and working capital.
- •Operates in niche speciality pharmaceuticals.
- •Risk flag: Low GMP suggesting no immediate listing gains
Sectors:pharma
AI-powered analysis by
Anadi Algo News